# Belatacept With Early Steroid Withdrawal rATG and Everolimus in Renal Transplantation (BETTER Trial)

> **NCT04849533** · PHASE4 · UNKNOWN · sponsor: **University of Cincinnati** · enrollment: 120 (estimated)

## Conditions studied

- Kidney Transplant Rejection

## Interventions

- **DRUG:** Belatacept
- **DRUG:** Everolimus
- **DRUG:** mycophenolate mofetil
- **DRUG:** corticosteroids
- **DRUG:** rabbit antithymocyte globulin

## Key facts

- **NCT ID:** NCT04849533
- **Lead sponsor:** University of Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-09
- **Primary completion:** 2023-07
- **Final completion:** 2024-07
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2021-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04849533

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04849533, "Belatacept With Early Steroid Withdrawal rATG and Everolimus in Renal Transplantation (BETTER Trial)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04849533. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*